Inflammation & Autoimmunity
Funding
LUPUSCARE
Patient Care & Referrals
Publications
Lab Members
Contact
GR
EN
Funding
COMPETITIVE FUNDING (2001 -2020)
Immunex USA –Investigator Initiated study, Anti-TNF for membranous neprhropathy Prinicipal Investigator (P.I 120.000€ total including drug).
General Secretarial for Research and Technology (GSTR), ΕPΕΑΕΚ (420.000 €)
Infrastructure for the Graduate Program, Molecular Basis of Human Disease. P.I
Pythagoras (ΕPΕΑΕΚ,). Pathogenesis of lupus nephritis. P.I (100.000 €)
FP-6 (AUTOCURE) Rheumatoid arthritis. Partner. (219.000 €).
SYNERGASIA (GSRT) Autoinflammation, (P.I total: 792.000 €, personal 150.000 €).
SYNERGASIA Inflammation and Atherosclerosis. Partner (110.000€)
SYNERGASIAImmune tolerance. Partner (150.000 €).
ARISTEIA (Autoimmune Search, GSRT, Autoimmunity (SLE) (P.I 332.000 €)
IMI BTCure Rheumatoid arthritis and related diseases. Partner (328.000 €).
Thalis (GSRT). Inflammation and dementia. Partner. (90.000 €)
FOREUM (Found for Rhem Res). Next generation sequencing in SLE. (PI Total 300.000)
SYSCID (IMI) 600.000 €
ERC ADVANCED GRANT (ΡΙ 2.350.000 €)
ΧΟΡΗΓΙΑ ΙΔΡ.ΩΝΑΣΗ - Β ΚΥΚΛΟΣ (20.000€)
--- Quick Links --------------------
BRFAA Home Page
Position Opportunities
Procurement
Funding
LUPUSCARE
Patient Care & Referrals
Publications
Lab Members
Contact
Boumpas Lab
Related Links
Functional Population Genomics and Genetic of Complex Traits Lab
George Bertsias
PLASMA ENABLED NANOFABRICATION AND APPLICATIONS GROUP
Πανεπιστημιακή Κλινική Ρευματολογίας, Κλινικής Ανοσολογίας και Αλλεργιολογίας της Ιατρικής Σχολής του Πανεπιστημίου Κρήτης